2025年1月7日 · Kapron 200 mg/100 ml IV Infusion is a second generation fluoroquinolone that is active against many Gram negative and Gram positive bacteria. It produces its action through inhibition of bacterial DNA gyrase and topoisomerase IV. Kapron 200 mg/100 ml IV Infusion binds to bacterial DNA gyrase with 100 times the affinity of mammalian DNA gyrase.

Detailed Tranexamic Acid dosage information for adults and children. Includes dosages for Menstrual Disorders and Bleeding; plus renal, liver and dialysis adjustments.

ion is intended for intravenous administration (intravenous injection and infusion). The recommended rate of administration is 50 mg/min. Undiluted Tranexamic acid solution for injection (100 mg/mL.

2025年1月7日 · Kapron is a second generation fluoroquinolone that is active against many Gram negative and Gram positive bacteria. It produces its action through inhibition of bacterial DNA gyrase and topoisomerase IV. Kapron binds to bacterial DNA gyrase with 100 times the affinity of mammalian DNA gyrase.

10-15 mg/kg IV over 20 minutes, THEN 1 mg/kg/hr continuous infusion for 6-10 hours. Long-term prophylaxis: 1000-1500 mg PO q8-12hr; reduce dose to 500 mg/dose PO qDay or q12hr when...

Kapron® ampoules, also known by their generic name Tranexamic Acid, belong to a category of medications called haemostatic drugs. These medications help to control bleeding by inhibiting fibrinolysis, the breakdown of blood clots.

2024年10月21日 · Tranexamic acid prevents enzymes in the body from breaking down blood clots. Cyklokapron is used to prevent bleeding in people with hemophilia who need to have a tooth pulled. This medication is usually given just before the dental procedure, and daily for up to 8 days afterward.

2024年4月22日 · Kapron Ampoule should be administered strictly via slow intravenous injection. The dosage and frequency depend on the patient’s age, weight, renal function, and the specific indication being treated.

2019年4月11日 · Cases of convulsions have been reported in association with tranexamic acid treatment. In coronary artery bypass graft (CABG) surgery, most of these cases were reported following intravenous (IV.) injection of tranexamic acid in high doses.

CYKLOKAPRON is an antifibrinolytic indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. (1) After Extraction: Administer 10 mg/kg actual body weight 3 to 4 times daily for 2 to 8 days.